One and done: Reasons principal investigators conduct only one FDA-regulated drug trial Posted on March 8, 2017February 6, 2025 by Hannah Faulkner One and done: Reasons principal investigators conduct only one FDA-regulated drug trial
Clinical Trial Electronic Portals for Expedited Safety Reporting: Recommendations from the Clinical Trials Transformation Initiative Investigational New Drug Safety Advancement Project Posted on December 15, 2016February 11, 2025 by Hannah Faulkner Clinical Trial Electronic Portals for Expedited Safety Reporting: Recommendations from the Clinical Trials Transformation Initiative Investigational New Drug Safety Advancement Project
Enhancing the Scientific Integrity and Safety of Clinical Trials: Recommendations for Data Monitoring Committees Posted on December 13, 2016January 31, 2025 by Hannah Faulkner Enhancing the Scientific Integrity and Safety of Clinical Trials: Recommendations for Data Monitoring Committees
Understanding the functions and operations of data monitoring committees: Survey and focus group findings Posted on November 25, 2016January 31, 2025 by Hannah Faulkner Understanding the functions and operations of data monitoring committees: Survey and focus group findings
Patient and physician attitudes regarding risk and benefit in streamlined development programmes for antibacterial drugs: a qualitative analysis Posted on November 10, 2016January 29, 2025 by Hannah Faulkner Patient and physician attitudes regarding risk and benefit in streamlined development programmes for antibacterial drugs: a qualitative analysis
Supplement: Facilitating Antibacterial Drug Development in a Time of Great Need Posted on August 1, 2016November 21, 2024 by Hannah Faulkner Supplement: Facilitating Antibacterial Drug Development in a Time of Great Need
Improving Conduct and Feasibility of Clinical Trials to Evaluate Antibacterial Drugs to Treat Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia: Recommendations of the Clinical Trials Transformation Initiative Antibacterial Drug Development Project Team Posted on August 1, 2016January 15, 2025 by Hannah Faulkner Improving Conduct and Feasibility of Clinical Trials to Evaluate Antibacterial Drugs to Treat Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia: Recommendations of the Clinical Trials Transformation Initiative Antibacterial Drug Development Project Team
How Public–Private Collaborations Are Driving Solutions to the Antibacterial Drug Development Crisis Posted on August 1, 2016January 15, 2025 by Hannah Faulkner How Public–Private Collaborations Are Driving Solutions to the Antibacterial Drug Development Crisis
Facilitating Antibacterial Drug Development in a Time of Great Need Posted on August 1, 2016January 15, 2025 by Hannah Faulkner Facilitating Antibacterial Drug Development in a Time of Great Need
Streamlining Safety Data Collection in Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia Trials: Recommendations of the Clinical Trials Transformation Initiative Antibacterial Drug Development Project Team Posted on August 1, 2016January 15, 2025 by Hannah Faulkner Streamlining Safety Data Collection in Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia Trials: Recommendations of the Clinical Trials Transformation Initiative Antibacterial Drug Development Project Team
